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ABSTRACT: Pyruvate phosphate dikinase (PPDK) catalyzes the interconversion of ATP, Pi, and pyruvate
with AMP, PPi, and PEP in three partial reactions: (1) E + ATP f EâATP f E-PPâAMP, (2) E-PPâ
AMP + Pi f E-PPâAMPâPi f E-PâAMPâPPi, and (3) E-P + pyruvate f E-Pâpyruvate f EâPEP.
The Clostridium symbiosum PPDK structure consists of N-terminal, central, and C-terminal domains.
The N-terminal and central domains catalyze partial reactions 1 and 2 whereas the C-terminal and central
domains catalyze partial reaction 3. The goal of the present work is to determine where on the N-terminal
domain catalysis of partial reactions 1 and 2 occurs and, in particular, where the Pi binding site is located.
Computer modeling studies implicated Arg337 as a key residue for Pi binding. This role was tested by
site-directed mutagenesis. The R337A PPDK was shown to be impaired in catalysis of the forward (kcat
300-fold lower) and reverse (kcat 30-fold lower) full reactions. Time courses for the single turnover reactions
were measured to show that catalysis of partial reaction 1 is 5-fold slower in the mutant, catalysis of the
second partial reaction is 140-fold slower in the mutant, and catalysis of the third partial reaction is
unaffected. With the exception of the mutation site, the crystal structure of the R337A PPDK closely
resembles the structure of the wild-type protein. Thus, the altered kinetic properties observed for this
mutant are attributed solely to the elimination of the interaction between substrate and the guanidinium
group of the Arg337 side chain. On the basis of these findings we propose that the Pi binding site is
located within the crevice of the PPDK N-terminal domain, at a site that is flanked by the ATP â-P and
the Mg2+ cofactor.
Pyruvate phosphate dikinase (PPDK)1 catalyzes the inter-
conversion of ATP, Pi, and pyruvate with AMP, PPi, and
PEP in the presence of Mg2+ and NH4
+ ion activators.
PPDK is found in certain microbes and in certain plants
where it functions in ATP production, replacing pyruvate
kinase, or in PEP formation, replacing pyruvate carboxylase
and PEP carboxykinase (1). The absence of PPDK in
animals, coupled with its essential functioning in parasitic
protists (e.g., Entamoeba histolytica, Giardia lamblia, and
Trichomonas Vaginalis), renders it a prime target for the
design of antiparasitic agents (2). The genes encoding PPDK
in Clostridium symbiosum, G. lamblia, E. histolytica, and
several plants have been cloned and sequenced (3, 4). The
gene products are of similar size (884-953 amino acids),
and the levels of amino acid identities existing between
the paired PPDK sequences are high, ranging from 50% to
60% for comparisons made between bacterial, protozoan and
plant enzymes. The high level of sequence identity which
exists between the dikinases is suggestive of a conserved
structure.
The three-dimensional structure of the C. symbiosum
apoPPDK was recently determined (5). The structure is
organized into three consecutive domains (Figure 1). Despite
the lack of significant sequence homology, the fold of the
N-terminal domain is similar to that of the nucleotide binding
domains of the ATP/ADP converting enzymes D-Ala-D-Ala
ligase (6), sucinnyl-CoA synthetase (7), and glutathione
synthase (8), indicating that the N-terminal domain of PPDK
may bind ATP. Affinity labeling studies carried out with
radiolabeled azidoATP and 2¢,3 ¢-dialdehyde AMP have
provided independent evidence that the nucleotide binding
site is indeed located on the N-terminal domain (9). The
central domain contains the catalytic histidine (His455) as
demonstrated by radiolabeling experiments carried out with
[32P]PEP (9, 10). The C-terminal domain is an R,â-barrel
similar in fold to the pyruvate binding domain of pyruvate
kinase (11). Site-directed mutagenesis and [14C]bromopy-
ruvate affinity labeling of the enzyme have confirmed the
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(Figure 1) (12). The determination of the location of the Pi
binding site on PPDK is the goal of the present study.
When bound to the N-terminal domain active site, the
catalytic histidine abstracts the ç,â-PP unit from ATP (to
form a pyrophosphorylated enzyme, E-PP) and then delivers
the ç-P to Pi (to form a phosphorylated enzyme, E-P) (13)
(see Scheme 1). When bound to the C-terminal domain
active site, located 45 Å away from the ATP site, the
phosphohistidine residue phosphorylates pyruvate. Studies
carried out with PPDK truncation mutants have shown that
only the N-terminal domain and central domain are required
to carry out the reaction steps: E + ATP + Pi f E-PPâ
PiâAMP f E-PâPPiâAMP (14). This observation suggests
that the Pi binding site is located on one of these two domains
or, possibly, at their interface.
The original C. symbiosum PPDK structure determination
was carried out on the apoenzyme crystallized from an
ammonium sulfate solution (5). Since then, conditions to
induce crystallization of the enzyme with metal cofactors
and substrate/product ligands bound have been screened but
have not yet produced crystals suitable for X-ray analysis.
An alternative approach has employed the analogy to the
structure of the D-Ala-D-Ala ligase-Mg2+-ADP-phosphi-
nophosphate complex (6) to deduce a feasible model for
Mg2+, ATP, and Pi binding sites within the apoPPDK crystal
structure (5, 9). On the basis of the orientation of ADP in
the ligase structure, the adenine ring of the ATP was placed
at the bottom of the cleft formed between the two â-sheets
of the PPDK N-terminal domain (Figure 2). This location
is consistent with the site of covalent labeling by photoaf-
finity agent azidoATP at the third â-strand from the front
(residues 320-327), right â-sheet shown in Figure 2. The
ATP tripolyphosphate moiety was modeled toward the
entrance of the cleft with the â-phosphoryl group aligned
with the attacking catalytic His455 (with its side chain
modified compared to the original apo structure). Two
arrangements of the ATP ç-phosphoryl group were found
to be compatible with the structure. In model A, the
ç-phosphoryl group interacts with a putative oxyanion hole
formed by the backbone amide NH of Met103 and Gly101.
It is also within an interaction distance of the Arg337
guanidinium group and the Lys22 ammonium group. There
is room for the Pi ligand on the opposite side of the â-P
where it will be within interaction distance of the Arg337
guanidinium group and the proposed site of the Mg2+
FIGURE 1: Ribbon diagram and simplified model of the C. symbiosum PPDK monomer adapted from ref 5 and illustrating the two
conformational states of the protein yellow central histidine domain bound to the green N-terminal nucleotide domain and the yellow
central histidine domain bound to the blue C-terminal pyruvate domain). The catalytic His455 residue is represented by a purple sphere,
and the discontinuity in the polypeptide chain observed in the crystal between residues 504 and 511 is marked. The first conformational
state (the N-terminal domain bound to the central domain) is observed for the apoPPDK crystal structure, and the second conformation (the
C-terminal domain bound to the central domain) has been obtained by a swivel motion of ca. 100° around residue 380.
Scheme 1: Partial Reactions of PPDK (15)
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group and Pi switch places. The ç-phosphoryl group now
binds to the Mg2+ and to Arg337 whereas the Pi is bound to
the backbone amide NHs of the oxyanion hole and to the
side chains of Lys22 and Arg337.
To test whether Pi binds to the ATP binding cleft as
suggested by the computer docking experiments, Arg337 was
mutated. Our prediction was that if the ligands are oriented
as shown in model A, the amino acid replacement may have
only a small inhibitory effect on ATP binding and on
catalysis of the E + ATP f E-PPâAMP partial reaction
but a stronger inhibitory effect on Pi binding and on catalysis
of the E-PPâPiâAMP f E-PâPPiâAMP partial reaction. If,
on the other hand, model B is correct, then mutation of
Arg337 should strongly inhibit ATP binding and catalysis
of the E + ATP f E-PPâAMP partial reaction while having
a lesser effect on Pi binding and catalysis of the E-PPâPiâ
AMP f E-PâPPiâAMP partial reaction. If both models A
and B are incorrect and ATP and Pi are bound at sites remote
from Arg337, then the kinetic properties of the Arg337
mutant are likely to be similar to those of wild-type PPDK.
In this paper we report on the preparation and steady-state
kinetic properties of the R337A and R337K PPDK site-
directed mutants as well as on the X-ray crystal structure
and pre-steady-state kinetic properties of the R337A PPDK
mutant. Our findings indicate that, consistent with model
A, Arg337 plays an important role in Pi binding and catalysis
of the E-PPâPiâAMP f E-PâPPiâAMP partial reaction and
a comparatively small role in ATP binding and catalysis of
the E + ATP f E-PPâAMP partial reaction.
MATERIALS AND METHODS
Materials. Plasmid pACYC184-D12 containing the cloned
C. symbiosum PPDK gene is described by Pocalyko et al.
(4). Escherichia coli JM101 cells (gift from John Gerlt) were
grown to mid-log phase in LB media (containing 12.5 íg/
mL tetracycline) at 37 °C before being harvested. Plasmid
FIGURE 2: Ribbon diagram of the N-terminal domain (green) of C. symbiosum PPDK with modeled ATP and Pi ligands (5) using the
orientation illustrated in model A. The atomic models of the two possible binding modes of ATP and Pi in the nucleotide binding site of
PPDK are shown below. Atomic colors are used as follows: carbon, gray; oxygen, red; nitrogen, blue; phosphorus, yellow; Mg2+, magenta.
Electrostatic interactions are shown as black dashed lines. The red arrow indicates the direction of attack of His455 on the â-phosphate of
ATP. Note that the side chain of His455 in the crystal structure (5) is not accessible to the active site, and its conformation was adjusted
for in-line attack on the â-phosphate.
PPDK Phosphate Site Biochemistry, Vol. 37, No. 39, 1998 13465DNA used for sequencing and mutagenesis was obtained by
using the method of Sambrook et al. (16). Primers used for
PCR and sequencing reactions were purchased from Oligos
Etc. Inc. Reagents used in PCR reactions were from the
GeneAmp kit supplied by Perkin-Elmer Cetus. Reagents
used in nucleotide sequencing were from the Sequenace kit
purchased from USB. Enzymes used for DNA manipulation
were purchased from New England Biolabs and from
Promega. Coupling enzymes and enzymes used in the
preparations of radiolabeled substrates were obtained from
Sigma. The radiolabeled substrates [ç-o râ-32P]ATP, [14C]-
ATP, and [14C]AMP were obtained from NEN. [14C]-
Pyruvate was purchased from Amersham. [32P]PEP was
synthesized from [â-32P]ATP according to the method
reported by Carroll et al. (13).
Site-Directed Mutagenesis. R337A and R337K PPDK
mutants were generated by using PCR techniques (17)i n
conjunction with a Thermolyne Temp Tronic thermocycler.
The primary PCR reactions contained 50 mM KCl, 10 mM
TrisâHCl (pH 8.3), 200 íM each of dATP, dCTP, dGTP,
and dTTP, 20 pM primer, 2.5 units of Taq DNA polymerase,
1.5 mM MgCl2, and 0.5 íg of template DNA (pACYC184-
D12). The inside primers corresponded to sequence 1072-
1089 while the outside primers corresponded to positions
926-942 and 2344-2360 (CGT to GCA change for R337A
and CGT to AAA change for R337K). Reactions were
overlaid with 50 íL of sterile silica oil. Primary PCR
reactions were carried out with denaturation at 92 °C for 1
min, annealing at 55 °C for 1 min, and extension at 72 °C
for 2 min (25 cycles). Secondary PCR reactions were carried
out using the following program: 2 min at 92 °C; 5 cycles
of 1 min at 92 °C, 1 min at 47 °C, 2 min at 72 °C, and 3
min at 25 °C; and 25 cycles of 1 min at 92 °C, 1 min at 50
°C, and 2 min at 72 °C. Following each PCR reaction,
samples were chromatographed on 1% LMP agarose elec-
trophoresis gels using TBE buffer (10.8 g/L Tris, 5.5 g/L
boric acid, 0.84 g/L EDTA). The DNA fragment was
extracted from the gel using the Geneclean II kit from Bio
101 and cut along with the pACYC184-D12 plasmid with
the restriction enzymes BstXI and KpnI. Following purifica-
tion on the 1% LMP agarose gel, the insert and linearized
plasmid were ligated using T4 DNA ligase, and the resulting
mixture was used to transform competent E. coli JM101 cells.
Mutant colonies were initially screened by restriction enzyme
digestion of plasmid DNA minipreps and then by nucleotide
sequencing using the chain termination method (18).
Purification of Wild-Type and Mutant PPDK. The mutant
and wild-type enzymes were purified as described in Wang
et al. (19) and then subjected to an additional Sephacryl
S-200 column chromatographic step [4 °C, 20 mM imidazole
Hydrochloride, 0.1 mM EDTA, 1 mM DTT, and 100 mM
KCl (pH 6.5) as eluant]. The enzyme was assayed during
purification using the published spectrophotometric assay
(19) and analyzed for purity at each stage by SDS-PAGE.
Steady-State Kinetic Analysis. (A). ATP-Forming Direc-
tion. The spectrophotometric assay (19) was used to monitor
the initial velocity of the PPDK-catalyzed reaction of AMP,
PPi, and PEP to ATP, Pi, and pyruvate. Initial velocities
were measured as a function of the concentration of the
varied substrate (in a range of 0.5-10-fold Km) at fixed,
saturating concentrations of cosubstrates (0.5 mM AMP, 0.5
mM PEP, and 1 mM PPi for wild-type PPDK and 2.5 mM
PPi for mutant PPDK) and metal ion cofactors (5 mM MgCl2
and 40 mM NH4Cl) in 20 mM imidazole (pH 6.8, 25 °C).
The initial velocity data were analyzed using eq 1. The kcat
was calculated from Vmax/[E].
where V0 is the initial velocity, [E] is the enzyme concentra-
tion, [S] is the substrate concentration, Vmax is the maximum
velocity, and Km is the Michaelis constant.
(B). AMP-Forming Direction. Reaction solutions (80 íL)
containing 1 íM wild-type PPDK or 20 íM mutant PPDK,
2m M[ 14C]ATP, 5 mM pyruvate, 5 mM Pi, 5 mM MgCl2,
10 mM NH4Cl, and 20 units of inorganic pyrophosphatase
(to drive the reaction to completion by catalyzing PPi
hydrolysis) in 50 mM K+Hepes (pH 7.0, 25 °C) were
quenched at specified times with 164 íL of 0.6 M HCl. The
protein was precipitated by vortexing the quenched reaction
with 100 íLo fC C l 4 and then removed by centrifugation.
ATP and AMP were separated from the supernatant by
HPLC using a 4.6 mm  25 cm Beckman ultrasphere C18
reversed-phase analytical column and 25 mM KH2PO4, 2.5%
triethylamine, and 5% methanol as eluant (1 mL/min flow
rate). The radioactivity of the ATP and AMP fractions was
determined by scintillation counting.
Rapid Quench Experiments. Single turnover reactions
were carried out by mixing 40 íL of buffered enzyme-metal
cofactor solution with 40 íL of buffered substrate (limiting
radiolabeled substrate and saturating unlabeled cosubstrate)
solution in a KinTek rapid quench at 25 °C. The reactions
were quenched at specified times with 164 íL of 0.6 M HCl.
The protein was precipitated by vortexing the quenched
reaction with 100 íLo fC C l 4 and then collected by
centrifugation. The protein pellet was analyzed for radio-
activity by dissolving it in 500 íL of boiling 10 N H2SO4
and then subjecting the resulting solution to scintillation
counting. The reaction sample supernatant fraction was
separated into product and reactant using HPLC techniques.
ATP and AMP were separated using a 4.6 mm  25 cm
Beckman Ultrasphere C18 reversed-phase analytical column
and 25 mM KH2PO4, 2.5% triethylamine, and 5% methanol
as eluant (1 mL/min flow rate). PEP and pyruvate were
separated using a 4.6 mm  25 cm Beckman ultrasil anion-
exchange column and 0.4 M KCl and 0.1 M KH2PO4 (pH
2.75) as eluant (1.5 mL/min flow rate). The amounts of
ATP, PPi, and Pi in the reaction supernatants were determined
by subjecting one 50 íL aliquot to HPLC chromatography
to separate the ATP for quantitation by liquid scintillation
counting. A second aliquot (50 íL) was added to 800 íL
of water and then mixed with 50 íL of 6 M HCl and 75 íL
of 250 mM ammonium molybdate. This solution was
extracted with an equal volume of a 1:1 2-propanol-water
mixture. The organic phase was assayed for [32P]Pi and the
aqueous layer for [32P]PPi by liquid scintillation counting.
The single turnover time courses were constructed by plotting
the concentration of reactant, intermediate, and/or product
present in the reaction as a function of reaction time. The
data were analyzed using the computer program Kalidograph
and a single exponential equation.
X-ray Crystallographic Analysis of R337A PPDK. The
crystallization conditions used for the C. symbiosum R337A
PPDK mutant were the same as those used for the wild-
V0 ) Vmax[E][S]/(Km + [S]) (1)
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vapor diffusion in hanging drops. Protein drops were
equilibrated against reservoir solutions containing 50-55%
saturated ammonium sulfate and 100 mM Hepes buffer, pH
7.0. The drops consisted of protein at 10 mg/mL, 20 mM
imidazole buffer, pH 6.5, 100 mM KCl, 0.1 mM EDTA,
and 1 mM mercaptoethanol diluted by an equal volume of
reservoir solution. The crystals belong to the space group
P2, and within the accuracy of the data the unit cell
dimensions are the same as those of the wild-type protein
crystals (Table 1). X-ray diffraction data were collected on
a Siemens area detector mounted on a three-circle goniostat,
with a monochromated Cu KR X-ray supplied by a Rigaku
Rotaflex RU200BH rotating anode generator. Data were
processed with the XENGEN package (20). Data collection
statistics are provided in Table 1. Initial structure refinement
was performed with the program X-PLOR (21). The
simulated annealing slow-cooling protocol at 3000 K was
followed by positional refinement cycles. Data between 8.0
and 2.5 Å for which F g 3ó(F) were included. Adjustments
to the model were made on a Silicon Graphics INDIGO II
computer graphics workstation using the program TURBO-
FRODO (22). The later stages of refinement were performed
with the program TNT (23) including data between 10 and
2.5 Å for which F g 2ó(F).
RESULTS
Purification and Characterization of R337A and R337K
PPDK. The R337A and R337K PPDK mutants were
generated using the pACYC184-D12 clone (4) in conjunction
with standard PCR techniques (17). Both mutants behaved
similarly to the wild-type PPDK during the purification steps,
eluting from the DEAE-cellulose and Sephacryl-200 columns
in the same positions as wild-type enzyme. The yield of
purified wild-type PPDK is 15 mg/g of cell, the yield of
R337A PPDK is 9 mg/g of cell, and the yield of R337K
PPDK is 3 mg/g of cell. The resistance of the purified
mutant enzymes toward proteolytic fragmentation during
storage in pH 7 buffer at 4 °C was examined over a 1 month
period and found to be the same as that of wild-type enzyme.
In previous studies of PPDK mutants we discovered that the
tendency of the enzyme to undergo fragmentation during
purification and/or prolonged storage is a reliable indicator
of unstable or nonnative-like structure (12). On the basis
of these criteria the R337A and R337K PPDK mutants
appear to have a native fold, which in the case of the R337A
PPDK was later confirmed by X-ray crystal structure
determination (see below).
Steady-State Kinetic Analysis of Wild-Type and Mutant
PPDK Catalysis. The PPDK-catalyzed reaction is fully
reversible, thus allowing kinetic measurements to be made
for the forward and reverse reaction directions. The ATP
+ Pi + pyruvate f AMP + PPi + PEP reaction was
monitored using a fixed time assay in which [14C]ATP is
used as the radiolabeled substrate and HPLC methods are
employed to separate unconsumed ATP and AMP product
from the quenched reaction solution. Inorganic pyrophos-
phatase was included to hydrolyze the PPi formed, thus
driving the reaction to completion. Saturating substrate and
cofactor concentrations were used (2 mM [14C]ATP, 5 mM
Pi, 5 mM pyruvate, 5 mM MgCl2, and 10 mM NH4Cl in 20
mM imidazole hydrochloride, pH 6.8) so that the initial
velocity of the reaction approximates the maximum velocity.
A plot of [14C]AMP concentration vs reaction time was
constructed for each of the three reactions (see Figures 1-3,
Supporting Information). The initial velocity was calculated
from the slope of the computer fit of the initial time points
to a linear equation. The ratio of the initial velocity (mM/
min; 0.32 ( 0.02 wild-type, 0.020 ( 0.0005 R337K, and
0.0053 ( 0.00004 R337A) and enzyme concentration (1 íM
wild-type PPDK, 2 íM R337K PPDK, or 20 íM R337A
PPDK) defines the kcat for the reaction providing that
cofactors and substrates are present in the reaction solution
at saturating concentrations. In the case of the wild-type
enzyme the saturating conditions are met (19) and, thus, kcat
) 5.4 s-1. The Km values for the three substrates with the
two mutants are not known and, therefore, the kcat ) 0.17
s-1 (R337K PPDK) and kcat ) 0.016 s-1 (R337A PPDK)
values determined here may be less than or equal to the true
kcat values. Nevertheless, the 30-fold decrease in the
observed kcat determined for R337K PPDK and the 300-fold
decrease in the observed kcat determined for R337A PPDK
indicate that Arg337 plays an important but not an essential
role in catalysis.
The AMP + PPi + PEP f ATP + Pi + pyruvate reaction
was monitored using a continuous spectrophotometric assay
in which pyruvate formation is coupled with lactate dehy-
drogenase catalyzed NADH oxidation (19). The initial
Table 1: Statistics of X-ray Crystallographic Data Collection for
R337A PPDK
space group P21
cell parameters a ) 89.9 Å, b ) 58.7 Å,
c )102.1 Å, â ) 95.2o
maximum resolution (Å) 2.5
no. of crystals used 1
no. of observations 97563
no. of unique reflections 35455
Rmerge
a 0.099
completeness (%) 95 (83)b
I/ó(I) 10.2 (1.2)b
a Rmerge) åhkl[(åijIi - áIñj)/åiIi]. b The values in parentheses cor-
respond to the highest resolution shell between 2.66 and 2.50 Å.
FIGURE 3: Time course for [32P]E-P formation in the single
turnover reaction of 40 íM enzyme, 5 íM[ 32P]PEP, 2.5 mM
MgCl2, and 10 mM NH4Cl in 50 mM K+HEPES (pH 7.0, 25 °C)
catalyzed by 40 íM( b) wild-type PPDK and (O) R337A PPDK.
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concentration was varied while the concentrations of the two
cosubstrates were saturating and fixed, were used to calculate
Vmax and Km. The results, summarized in Table 2, show that
kcat is reduced 3-fold for R337K PPDK and 30-fold for
R337A PPDK. The Km values measured for the mutants
deviate significantly from those of wild-type only in the case
of the PPi substrate. For R337K PPDK the PPi Km is
increased 7-fold and for R337A PPDK, 20-fold. This result
suggests that Arg337 may play an important role in the E-P
+ AMP + PPi f E + ATP + Pi partial reaction (see Scheme
1).
Transient Kinetic Analysis of Wild-Type and Mutant PPDK
Catalysis. The rates of the three PPDK partial reactions
represented in Scheme 1 were measured by carrying out
single turnover reactions with PPDK and specifically radio-
labeled substrate. A rapid quench device was used to mix
a solution of radiolabeled substrate and cosubstrate/cofactors
with a solution of enzyme and, then, to terminate the reaction
after a specified period of time by the addition of acid. The
composition of the quenched reaction mixture was deter-
mined by first separating radiolabeled enzyme by precipita-
tion and then radiolabeled substrate and product by HPLC.
The enzyme, reactant, and product fractions were quantitated
by liquid scintillation counting. For the first set of experi-
ments, [32P]PEP was used as substrate to monitor phospho-
rylenzyme formation in the EâPEP f E-Pâpyruvate partial
reaction and [14C]AMP was used as substrate to monitor ATP
formation from the E-PâAMPâPPi f E-PPâAMPâPi f Eâ
ATPâPPi reaction sequence. For the second set of experi-
ments, [14C]ATP was used as substrate and [14C]AMP
formation from EâATP f E-PPâAMP and from EâATPâPi
f E-PPâAMPâPi f E-PâAMPâPPi was monitored. For
the last set of experiments [ç-ATP] was used as substrate
and the formation of 32P-labeled E-PP and [32P]PPi was
measured.
The single turnover experiments were carried for the
purpose of determining which of the three partial reactions
(Scheme 1) is inhibited by the replacement of Arg337. If
model A (Figure 2) is correct, R337A PPDK is predicted to
be strongly inhibited in the catalysis of partial reaction 2,
moderately inhibited in the catalysis of partial reaction 1,
and not inhibited in the catalysis of partial reaction 3. If,
on the other hand, model B is correct, catalysis of partial
reaction 1 will be strongly inhibited, catalysis of partial
reaction 2 moderately inhibited, and catalysis of partial
reaction 3 unaffected.
The first step taken was to show that the rate of a single
turnover of E + PEP f E-P + pyruvate (partial reaction
3) is unaffected by the Arg337 mutation. Figure 3 shows
the time courses for the single turnover reactions of 40 íM
wild-type or R337A PPDK with 5 íM[ 32P]PEP. The data
were fit to a single exponential equation to yield kobs ) 45
( 8s -1 for wild-type PPDK and kobs ) 25 ( 5s -1 for R337A
PPDK. It is clear from these data that R337A PPDK
catalyzes the E + PEP f E-P + pyruvate partial reaction
as efficiently as does wild-type PPDK. Figure 4, on the other
hand, shows the time courses for the single turnover reactions
Table 2: Steady-State Kinetic Constants for Wild-Type PPDK,
R337A PPDK, and R337K PPDK Catalysis
(I) Reaction: ATP + Pi + pyruvate f AMP + PPi + PEPa
enzyme Vmax (mM/min) kcat (s-1)
wild type (1 íM) 0.32 ( 0.02 5.4
R337A (20 íM) 0.019 ( 0.0008a 0.016
R337K (2 íM) 0.020 ( 0.0005a 0.17
(II) Reaction: AMP + PPi + PEP f ATP + Pi + pyruvateb
sample Km (mM) Vmax (mM/min) kcat (s-1)
wild type (0.016 íM)
vary AMPc 0.007 ( 0.0005 0.026 ( 0.001 26
vary PPi
d 0.07 ( 0.01 0.035 ( 0.004 30
varyPEPe 0.027 ( 0.0005 0.029 ( 0.0004 36
R337A (0.22 íM)
vary AMPf 0.006 ( 0.0005 0.014 ( 0.0004 1.1
vary PPi
d 1.14 ( 0.121 0.019 ( 0.001 1.4
vary PEPg 0.009 ( 0.0006 0.010 ( 0.0002 0.8
R337K (0.032 íM)
vary AMPf 0.006 ( 0.003 0.016 ( 0.0004 8.2
vary PPi
d 0.477 ( 0.04 0.020 ( 0.0007 10.4
vary PEPg 0.021 ( 0.002 0.016 ( 0.0006 8.3
a 2m M[ 14C]ATP, 5 mM pyruvate, 5 mM Pi, 20 units of inorganic
pyrophosphatase, 5 mM MgCl2,1 0m MN H 4Cl, and 50 mM K+Hepes
(pH 7.0, 25 °C). b 20 mM imidazole hydrochloride (pH 6.8), 40 mM
NH4Cl, and 5 mM MgCl2 at 25 °C. c Reactions contained 1.0 mM PPi
and 0.5 mM PEP. d Reactions contained 0.5 mM AMP and 0.5 mM
PEP. e Reactions contained 1.0 mM PPi and 0.5 mM AMP. f Reactions
contained 2.5 mM PPi and 0.5 mM PEP. g Reactions contained 2.5 mM
PPi and 0.5 mM AMP.
FIGURE 4: Time course for [14C]ATP formation in the single
turnover reaction of 40 íM enzyme, 80 íM PEP, 6 íM[ 14C]AMP,
2m MP P i, 5 mM MgCl2, and 10 mM NH4Cl in 50 mM K+HEPES
(pH 7.0, 25 °C). Panels: (A) wild-type PPDK and (B) R337A
PPDK.
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íM[ 14C]AMP + 4m MP P i. The data were fit to a single
exponential equation to yield kobs ) 15 ( 1s -1 for wild-
type PPDK and kobs ) 0.59 ( 0.02 s-1 for R337A PPDK.
From these data we conclude that the Arg337 mutant
catalyzes the E + AMP + PPi + PEP f E + ATP + Pi +
pyruvate reaction 30-fold less efficiently than wild-type
PPDK. Together, the kinetic data in Figures 3 and 4 indicate
that the replacement of Arg337 does not inhibit catalysis of
E + PEP f E-P + pyruvate (partial reaction 3) but it does
inhibit catalysis of E-P + AMP + PPi f E + ATP + Pi
(partial reactions 2 and 1).
The next step was to determine which partial reaction, E
+ ATP f E-PPâAMP or E-PPâAMP + Pi f E-PâAMPâ
PPi, is inhibited by the Arg337 replacement. First, the rate
of the E + ATP f E-PPâAMP reaction catalyzed by R337A
PPDK was measured and compared to that catalyzed by wild-
type PPDK. This was accomplished by reacting limiting
[14C]ATP (5 íM) with excess enzyme (40 íM) in the
presence of saturating Co2+ and NH4
+ cofactors and measur-
ing the time course for [14C]AMP formation in the enzyme
active site during a single turnover. Co2+ was used in this
reaction in place of the physiological Mg2+ cofactor for the
purpose of enhancing the yield of the E-PPâAMP product
formed at equilibrium.2 For wild-type PPDK, the rate
constant for ATP binding is ca. 5 íM-1 s-1 while the rate
constant for EâATP f E-PPâAMP is ca. 600 s-1 (15). Thus,
under the reaction conditions employed, both ATP binding
and catalysis are partially rate limiting.
Figure 5 shows the time courses for [14C]AMP formation
catalyzed by Co2+ activated wild-type and R337A PPDKs.
The product yield observed at equilibrium was 37% in the
case of the wild-type enzyme and 70% in the case of the
R337A mutant. The data were fit to a single-exponential
equation to give a kobs ) 160 ( 30 s-1 for wild-type PPDK
and kobs ) 33 ( 4s -1 for R337A PPDK. These data indicate
that Co2+ activated R337A PPDK catalyzes the E + ATP
f E-PPâAMP reaction at a rate 5-fold slower than that of
the wild-type enzyme.
Next, the effect of the Arg337 mutation on catalysis of
the E-PPâAMP + Pi f E-PâAMPâPPi partial reaction was
examined. The assay for E-PâAMPâPPi employed HPLC
separation of unconsumed [14C]ATP reactant and [14C]AMP
product from the acid-quenched single turnover reactions of
5 íM[ 14C]ATP, 20 íM PPDK, and 11 mM Pi .M g 2+ was
used as the cofactor so that the equilibrium ratio of [E-PPâ
AMP]/[EâATP] would be small (viz. ca. 0.2) (15). Thus,
the majority (i.e., ca. 80%) of the AMP formed from a single
turnover on the enzyme is generated by the E-PPâAMP +
Pi f E-PâAMPâPPi step, which is driven to completion by
the high concentration of Pi present in the reaction. The
rate data measured with wild-type PPDK and shown in
Figure 6A were fit with a single exponential equation to give
kobs ) 5.7 ( 0. 3 s-1 for the combined reaction steps.3 On
the other hand, the rate data measured with R337A PPDK
(Figure 6B) define a biphasic curve. The fast phase
accounted for ca. 0.8 íM[ 14C]AMP product formed while
the ensuing slow phase accounted for an additional 3.5 íM
[14C]AMP. The two sets of data points were independently
fit to a single exponential equation to yield k1obs ) 140 (
40 s-1 and k2obs ) 0.04 ( 0.002 s-1, where k1obs reflects the
rate of the E + ATP f E-PPâAMP partial reaction and
k2obs reflects the rate of the E-PPâAMP + Pi f E-PâAMPâ
PPi partial reaction.4
Demonstration of PPi and PEP Product Formation Cata-
lyzed By R337A PPDK. For the kinetic experiments
described in the previous section, R337A PPDK catalyzed
AMP formation from the reaction of [14C]ATP + Pi +
pyruvate was demonstrated by the isolation of [14C]AMP.
On the other hand, the formation of PPi and PEP in this
reaction was assumed. The knowledge that kinases com-
monly possess intrinsic ATPase activities prompted us to
consider alternate hydrolytic pathways involving E-PP or
E-P which could allow additional catalytic cycles to occur
in the absence of PPi and/or PEP product formation.
Although hydrolysis is not detected in catalysis by wild-
type PPDK, the altered active site of the R337A PPDK
mutant may facilitate this process. To demonstrate that Pi
is the acceptor of the terminal phosphoryl group from E-PP
and pyruvate, the acceptor of the phosphoryl group from
2 The internal equilibrium constant E-PPâAMP/EâATP is 0.2 in the
case of the Mg2+-activated enzyme and 0.4 in the case of the Co2+-
activated enzyme (15). In addition, the dissociation constant for Eâ
ATP is ca. 100 íM in the case of the Mg2+-activated enzyme and ca.
10 íM in the case of the Co2+-activated enzyme. Thus, in the
equilibrium mixture generated from 5 íM[ 14C]ATP and 40 íM PPDK
the concentration of E-PPâAMP is significantly higher with Co2+-
PPDK than it is with Mg2+-PPDK. As a result, the time course for
E-PPâAMP formation by the Co2+-activated PPDK is more accurately
measured since the radioactivity associated with the [14C]AMP product
fraction is that much higher (ca. 30% of the total reactivity for wild-
type PPDK) than that found for the control reaction (ca. 1% of the
total radioactivity).
3 On the basis of the rate constants obtained in previous kinetic
measurements (15) and on the substrate concentrations used in the
present reaction, the ATP and Pi binding steps are predicted to be rate
limiting.
4 We note that the value of the rate constant obtained for the small
burst is only an estimate of the actual rate constant. Data points defining
the initial portion of the time course could not be obtained, and thus,
the curve was extrapolated from later time points to a value of 0 at
time 0.
FIGURE 5: Time course for [14C]AMP formation in the single
turnover reaction of 40 íM enzyme, 5 íM[ 14C]ATP, 5 mM CoCl2,
and 10 mM NH4Cl in 50 mM K+Hepes (pH 7.0, 25 °C) for (O)
wild-type PPDK and (4) R337A PPDK.
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beled substrates and the time courses for [32P]PPi and [14C]-
PEP formation were monitored.
Figure 7 shows the time course for E-PP and PPi
formation and ATP consumption in the single turnover of
[ç-32P]ATP + Pi + pyruvate catalyzed by wild-type PPDK
and R337A PPDK. The levels of E-PP formed in the first
reaction step (E + ATP f E-PPâAMP) catalyzed by the
two enzymes are comparable (kobs ) 300 s-1 for wild-type
PPDK and 80 s-1 for R337A PPDK).4 PPi formation from
the second step (E-PPâAMP + Pi f E-PâAMPâPPi)o ft h e
reaction was observed for both mutant PPDK (kobs ) 0.04
s-1) and wild-type PPDK (kobs ) 100 s-1).
Figure 8 shows the steady-state time course for PEP
formation and pyruvate consumption in the multiple turnover
reactions of ATP + Pi + [14C]pyruvate catalyzed by wild-
type PPDK and R337A PPDK. It is evident from these
profiles that PEP is formed by R337A PPDK (V0/[E] ) 0.004
s-1) but at a comparatively slower rate than by wild-type
PPDK (V0/[E] ) 1.2 s-1).
X-ray Crystal Structure of R337A PPDK. The current
model has a conventional R-factor of 0.180 for the 26 796
reflections between 10.0 and 2.5 Å resolution for which F
g 2ó(F)( R-factor ) åhkljjFoj - jFcjj/åhkljFoj, where Fo and
Fc are the observed and calculated structure factors). The
stereochemical parameters are well within the range known
from crystal structures of small peptides. The root-mean-
square (rms) deviations from ideal values for bond lengths
and bond angles of the standard geometry as compiled by
Engh and Huber (24) are 0.018 Å and 2.8°, respectively.
The model includes 869 of the 874 amino acid residues (the
N-terminal methionine and residues 506-509 are associated
with regions of low electron density), 78 water molecules,
and 1 sulfate ion. Within the accuracy of the structure
determination, the overall structure is the same as that of
the wild-type protein (Figure 9) (5). The CR atomic
coordinates of the mutant and wild-type molecules super-
impose with a rms deviation of 0.5 Å (Figure 10). The
electron density map at the mutation site is consistent with
the replacement of an arginine by an alanine residue (Figure
9). A water molecule, WAT2, replaces a sulfate ion that is
present in the wild-type PPDK structure, coordinated to
Arg337, Lys22, and an oxyanion hole formed by the
backbone amide NH groups of Gly101 and Met103 (5). A
slight shift of the 99-105 peptide segment accompanies the
removal of the sulfate ion.
FIGURE 6: Time course for [14C]AMP formation in the single
turnover reaction of 20 íM enzyme, 5 íM[ 14C]ATP, 11 mM Pi,5
mM MgCl2, and 10 mM NH4Cl in 50 mM K+Hepes (pH 7.0, 25
°C). Panels: (A) wild-type PPDK and (B) R337A PPDK.
FIGURE 7: Time course for a single turnover reaction of 6 íM
[ç-32P]ATP, 2 mM Pi, 1 mM pyruvate, 3 mM MgCl2, and 10 mM
NH4Cl in 50 mM K+Hepes (pH 7.0, 25 oC) catalyzed by 34 íM
(A) wild-type PPDK and (B) R337A PPDK. (O). Data points were
not included in the exponential fit to the progress curve.
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The goal of this work is to determine the location of the
Pi binding site within the three-domain structure of PPDK
represented in Figure 1. The ATP binding site is located in
the crevice formed between the two â-sheets of the N-
terminal domain (Figure 2). Computer modeling experi-
ments suggested placing the Pi in this crevice to the right-
hand (model A) or left-hand side (model B) of the ATP â-P.
In either arrangement both the ATP ç-P and Pi interact with
the guanidinium side chain of Arg337. Thus, replacement
of Arg337 with an amino acid which cannot interact
favorably with the negatively charged substrates should
inhibit the EâATPâPi f E-PPâAMPâPi f E-PâAMPâPPi
reaction sequence, provided that one of the two models
proposed in Figure 2 is correct.
Kinetic Study of Arg337 PPDK Mutants. For this study
two mutants were prepared: R337K PPDK and R337A
PPDK. Steady-state kinetic analysis of the catalysis of the
full reaction in the forward and reverse directions showed
that both mutants were catalytically impaired (Table 2). The
R337A PPDK was found to be less active than the R337K
PPDK, indicating that the positively charged Lys side chain
at position 337 is more effective in facilitating catalysis than
is the methyl substituent of the Ala residue. Surprisingly,
close inspection of the composition of the product mixture
generated with R337K PPDK revealed that ATP hydrolysis
to ADP occurs in competition with the normal reaction
pathway. The ATPase activity was not observed with
R337A PPDK. The Lys residue at position 337 thus appears
to promote the addition of water to the â-P of the ATP. To
avoid complications deriving from this competing reaction,
the transient kinetic studies described below were carried
out with R337A PPDK. Before executing these kinetic
experiments, however, the formation of PPi (Figure 7) and
PEP (Figure 8) as products was first demonstrated (using
[ç-32P]ATP and [14C]pyruvate) to rule out the possibility of
other unwanted side reactions (e.g., hydrolysis of E-PP or
E-P) during R337A PPDK catalysis.
The transient kinetic studies of R337A PPDK catalysis
were carried out for the purpose of determining which of
the three partial reactions shown in Scheme 1 is inhibited
by the Ala substitution for Arg337. Our prediction was that
if the ATP and Pi ligands are oriented in the active site as
shown in model A, the amino acid replacement at position
337 may have only a small inhibitory effect on ATP binding
and on catalysis of the E + ATP f E-PPâAMP partial
reaction (since the interaction with Arg337 is only one of
several electrostatic interactions occurring with the ç-P) but
a stronger inhibitory effect on Pi binding and on catalysis of
the E-PPâPiâAMP f E-PâPPiâAMP partial reaction (since
interaction with Arg337 is the principal interaction of the Pi
with the protein). If, on the other hand, model B is correct,
then mutation of Arg337 should strongly inhibit ATP binding
and catalysis of the E + ATP f E-PPâAMP partial reaction
(Arg337 contributes the only electrostatic interaction between
the protein and the ç-P) while having a lesser effect on Pi
binding (Pi interacts with the backbone amide NHs of the
oxyanion hole and with the side chains of Lys22 and Arg337)
and catalysis of the E-PPâPiâAMP f E-PâPPiâAMP partial
reaction. Both models predict that the third partial reac-
tion, E-Pâpyruvate f EâPEP will not be affected by the
amino acid replacement at Arg337 since this reaction occurs
on an entirely different domain of the PPDK structure (Figure
1).
The profiles (Figure 3) and rate constants (Table 3)
obtained for the single turnover of E + [32P]PEP f E-Pâ
pyruvate measured for wild-type PPDK and R337A PPDK
demonstrate that the substitution of Arg337 with Ala has
not significantly altered catalysis of partial reaction 3
(Scheme 1). The profiles (Figure 5) and rate constants (Table
3) measured for the E + [14C]ATP f E-PPâ[14C]AMP partial
reaction indicate that catalysis occurs ca. 5-fold slower in
the mutant enzyme than in the wild-type PPDK. The profiles
(Figure 6) and rate constants (Table 3) observed for the
sequential reactions E + [14C]ATP + Pi f E-PPâ[14C]AMPâ
Pi f E-Pâ[14C]AMPâPPi indicate that the E-PPâ[14C]AMPâ
Pi f E-Pâ[14C]AMPâPPi step is catalyzed by R337A PPDK
at a rate that is ca. 140-fold slower than that observed for
wild-type PPDK. These results suggest that the Pi binding
site is located to the right of the ATP â-P within the PPDK
N-terminal domain, as is illustrated in model A of Figure 2.
There are two other pieces of experimental data which
support the ligand arrangement shown in model A over that
shown in model B. First, Pi binding is weak (Kd > 1 mM)
(15), and second, it follows ATP binding (19). Both
properties are more compatible with ç-P binding to the
putative oxyanion hole and Pi binding to the left, thereby
desolvating the ç-P.
Structural Analysis of R337A PPDK. With the exception
of the mutation site, the crystal structure of the R337A PPDK
(Figures 9 and 10) closely resembles the structure of the wild-
type protein. Thus, the altered kinetic properties observed
for this mutant are attributed solely to the elimination of the
interaction between substrate and the guanidinium group of
the Arg337 side chain. We note that the sulfate ion bound
to the Arg337 guanidinium ion in the wild-type PPDK crystal
is absent (i.e., replaced by a water molecule; Figure 9) from
the crystal structure of R337A PPDK. This sulfate ion
occupies the same position occupied by the ç-P of ATP in
model A (Figure 2). The reduction in binding affinity for
FIGURE 8: Time course for [14C]PEP formation and [14C]pyruvate
consumption in the reaction of 2 mM ATP, 5 mM [14C]pyruvate,
5m MP i, 20 units of inorganic pyrophosphatase, 5 mM MgCl2,
and 10 mM NH4Cl in 50 mM K+Hepes (pH 7.0, 25 oC) catalyzed
by (b)1íM wild-type PPDK or (O)2 0íM R337A PPDK.
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the ç-P of the ATP may also occur in R337A PPDK.
Assuming that this interaction contributes to productive
binding and/or transition state stabilization, it may explain
why a (5-fold) reduction in the rate of nucleophilic displace-
ment of the ç-P â-P unit from ATP is observed for the mutant
enzyme (Table 3).
Proposed Mechanism of Catalysis. The reaction sequence
shown in Figure 11 summarizes the interactions that may
occur between Mg2+ cofactor, substrate ligands, and enzyme
active site residues during catalytic turnover of ATP and Pi
(Figure 2). The precise positioning of the substrate/
intermediate/product/Mg2+ ligands shown is purely hypo-
thetical as are the interactions envisioned to occur between
FIGURE 9: (Top) Electron density map showing the mutation site of the R337A PPDK mutant. The map is contoured at the 1.2ó level with
map coefficients (2Fo-Fc) and calculated phases. Two water molecules, WAT1 and WAT2, are coordinated to Lys22. WAT2 is located in
an equivalent position to a sulfate ion in the wild-type structure (Bottom).
FIGURE 10: Superposition of R337A PPDK (thick lines) and wild-type PPDK (thin lines) N-terminal (ATP/Pi binding) and central (catalytic
His455) domains. The PEP/pyruvate binding domain (residues 534-874) and residues 109-200 are omitted here for the sake of clarity.
Side chains of residues 337, Lys22, and His455 are shown and labeled. As a result of the mutation, a water molecule replaces the Arg337
coordinated sulfate ion present in wild-type PPDK.
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simply a working model for PPDK catalysis that will be
tested in future studies. The location selected for the ATP
binding site is based on the results from previous affinity
labeling studies (9) and on the superposition of the ADP
liganded D-Ala-D-Ala ligase (6) with apoPPDK (5, 9). From
previous kinetic studies (15) we know that the Pi binding
step can (and at moderate Pi concentrations surely does) occur
after ATP has bound and reacted with the enzyme His455.
Thus, in our model we show the first step of the reaction
occurring from the enzymeâMgâATP Michaelis complex.
While the Mg2+ ligands have not yet been identified, the
coordination of Mg2+ to Glu323 shown in Figure 11 is
consistent with the results from site-directed mutagenesis
experiments which have demonstrated that Glu323 is es-
sential for PPDK catalysis (25). This arrangement places
Mg2+ within interaction distance of the ATP R-P and â-P.
Studies aimed at identifying the actual Mg2+ enzyme ligands
and ATP coordination sites are in progress.
In the model, the ç-P of the ATP is proposed to engage
in electrostatic interactions with the backbone amide NHs
of Gly101 and Met103, with the guanidinium group of
Arg337, and with the ammonium group of Lys22. Lys22 is
essential for ATP turnover (25), and Arg337 facilitates ATP
turnover (this study). The backbone region containing
Gly101 and Met103 appears to form a classical oxyanion
hole however, its actual function has yet to be experimentally
tested. His455 of the central domain is oriented for in-line
Table 3: Rate Constants for Single Turnover Reactions Catalyzed
by R337A PPDK and Wild-Type PPDK in 50 MM K+Hepes (pH
7.0) at 25 °C
(I) Reaction (Mg2+/NH4
+): E (40 íM) + [32P]PEP (5 mM) f
[32P]E-PâPyruvate
wild-type PPDK kobs ) 45 ( 8s -1
R337A PPDK kobs ) 25 ( 5s -1
(II) Reaction (Mg2+/NH4
+): E (40 íM) + [14C]AMP (6 íM) +
PPi (2 mM) + PEP (80 íM) f E + [14C]ATP + Pi+ Pyruvate
wild-type PPDK kobs ) 15 ( 1s -1
R337A PPDK kobs ) 0.59 ( 0.02 s-1
(III) Reaction (Co2+/NH4
+): E (40 íM) + [14C]ATP (5 íM) f
E-PPâ[14C]AMP
wild-type PPDK kobs ) 160 ( 30 s-1
R337A PPDK kobs ) 33 ( 4s -1
(IV) Reaction (Mg+2/NH4
+): E (20 íM) + [14C]ATP (5 íM) +
Pi(11 mM) f E-PPâ[14C]AMP + Pif E-Pâ[14C]AMPâPPi
wild-type PPDK kobs ) 5.7 ( 0.3 s-1
R337A PPDK k1obs ) 140 ( 40 s-1
k2obs ) 0.04 ( 0.002 s-1
(V) Reaction (Mg2+/NH4
+): E (20 íM) + [ç-32P]ATP (5 íM) +
Pi(11 mM) f [32P]E-PPâAMP + Pif E-Pâ[14C]AMPâ[32P]PPi
wild-type PPDK kobs ) 300 ( 100 s-1 (E-PP formation)
kobs ) 100 ( 32 s-1 PPi formation
R337A PPDK kobs ) 80 ( 40 s-1E-PP formation
kobs ) 0.04 ( 0.02 s-1 PPi formation
FIGURE 11: Hypothetical three-dimensional model for the progress of the two phosphoryl group transfer reactions that occur in the nucleotide
binding site of PPDK. The color scheme is the same as that used in Figure 2. See text for details.
PPDK Phosphate Site Biochemistry, Vol. 37, No. 39, 1998 13473attack of the ATP â-P. As the E-PPâMgâAMP complex is
formed, the ç-P is envisioned to rotate away from Lys22
and the oxyanion hole, toward the Pi site. On the basis of
the studies presented in this paper, Pi is believed to bind to
Arg337. Although not yet tested, Mg2+ may also bind the
Pi ligand to generate the E-PPâMgâAMPâPi complex rep-
resented in Figure 11. In this complex, the E-PP may be
activated for in-line attack by the Pi through interaction of
the ç-P with Arg337 and the â-P with the backbone amide
NH of Gly101. Future crystallographic and mutagenesis
studies will serve as a test for this proposed model of PPDK
catalysis.
SUPPORTING INFORMATION AVAILABLE
Figures 1-3 showing the time courses for the full reaction
of ATP, Pi, and pyruvate with wild-type, R337A, and R337K
PPDK (5 pages). Ordering information is given on any
current masthead page.
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